Remove Drugs Remove Gene Therapy Remove Genotype Remove Protein
article thumbnail

Discover how iPSC derived cells can support drug and gene therapy development

Drug Discovery World

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. Chris explained that DefiniGEN is a liver cell company focussed on hepatocytes, particularly supporting the drug development industry in producing liver therapies.

article thumbnail

Using iPSC derived cells for the development of drug and gene therapies

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. However, hepatoma lines may lack the key proteins essential for modeling. Register for free here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Register now to discover how iPSC derived cells support gene therapy development

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. However, hepatoma lines may lack the key proteins essential for modeling. Register for free here.

article thumbnail

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

Drug Discovery World

However, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. Initial screening of treatments may utilise the highly proliferative Chinese Hamster Ovarian (CHO) or Human Embryonic Kidney (HEK) cell lines with the liver protein(s) of interest exogenously expressed.

article thumbnail

How can iPSC derived cells can be used to support drug development?

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. However, hepatoma lines may lack the key proteins essential for modeling. appeared first on Drug Discovery World (DDW).

article thumbnail

Last chance: Discover how iPSC derived cells support drug development

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. However, hepatoma lines may lack the key proteins essential for modeling. Register for free here.

article thumbnail

Congenital fibrinogen deficiency market forecast to reach $800m across 3MM by 2031

Pharmaceutical Technology

High interest has sparked across the CFD drug space as more experts are becoming aware of the clinical efficacy and large market opportunity of using HFC products to treat various AFD indications, including surgeries involving massive blood loss and unexpected trauma. While they treat the symptoms of CFD, they are not curative.

Marketing 130